Construction of a Prognostic Model for Severe Brain-Injured Patients Based on Integrated Metabolic-Neurological Monitoring

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorXingui Dai

About this trial

This is a prospective, observational cohort study aimed at constructing a machine learning-based prognostic model for severe brain-injured patients. The study will synchronously collect continuous glucose monitoring (CGM), electroencephalography (EEG), near-infrared spectroscopy (fNIRS), transcranial Doppler (TCD), and serum neuronal injury biomarkers (NSE, S100β) within 72 hours post-injury. The goal is to investigate the correlation between glycemic variability (GV) and neurological function and to develop an integrated model for early prediction of 3-6 month neurological outcomes (GOSE score).

Eligibility criteria

Qualifiers

Diagnosis of severe TBI, large-volume stroke, or HIE

Expected ICU stay >72 hours

Informed consent from legal surrogate

Disqualifiers

Terminal organ failure

Pre-existing severe neurological disease

Skull defect preventing monitoring

Pregnancy or lactation

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

Xingui Dai

Lead sponsor

First People's Hospital of Chenzhou

Sponsor institution